Inventor
ALAN SHULDINER
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms17%
C12YEnzymes10%
C07KPeptides7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
PatentTitleYear
12,509,687Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors202512,480,103B4GALT1 variants and uses thereof202512,359,20117ss-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof202511,845,963HSD17B13 variants and uses thereof202311,753,628HSD17B13 variants and uses thereof202311,713,461Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors202311,504,390Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors202211,485,958HSD17B13 variants and uses thereof202211,331,332Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors202211,180,75717b-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to REGENERON PHARMA (10)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to UNIV MARYLAND (5)· patent assignee history
2023Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 10 | 2021–2025 |
| UNIV MARYLAND | 5 | 2022–2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2021–2025 |